Clinical Trial Update: First Time in Human Study of Long Acting VH4524184 Formulations [Phase 1]

View source ↗

Summary

First-in-human study of long-acting VH4524184 formulations for HIV infection, currently recruiting in Phase 1.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Immunodeficiency Virus Infection

Drugs mentioned

• VH4524184

Snippet

Sponsor: ViiV Healthcare | Conditions: HIV Infections | Phase 1 | Status: RECRUITING